Jane Street’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $368K | Buy |
48,883
+14,487
| +42% | +$109K | ﹤0.01% | 4069 |
|
|
2025
Q1 | $260K | Buy |
34,396
+19,813
| +136% | +$150K | ﹤0.01% | 4714 |
|
|
2024
Q4 | $178K | Sell |
14,583
-6,572
| -31% | -$80K | ﹤0.01% | 5151 |
|
|
2024
Q3 | $354K | Sell |
21,155
-75,441
| -78% | -$1.26M | ﹤0.01% | 4697 |
|
|
2024
Q2 | $1.68M | Buy |
96,596
+75,592
| +360% | +$1.32M | ﹤0.01% | 2962 |
|
|
2024
Q1 | $358K | Buy |
21,004
+7,202
| +52% | +$123K | ﹤0.01% | 4442 |
|
|
2023
Q4 | $141K | Sell |
13,802
-2,812
| -17% | -$28.7K | ﹤0.01% | 5153 |
|
|
2023
Q3 | $150K | Sell |
16,614
-37,269
| -69% | -$337K | ﹤0.01% | 4513 |
|
|
2023
Q2 | $580K | Buy |
53,883
+32,196
| +148% | +$346K | ﹤0.01% | 3624 |
|
|
2023
Q1 | $222K | Buy |
+21,687
| New | +$222K | ﹤0.01% | 4592 |
|